Skip to content

NASCENT BIOTECH, INC.

CIK 0001622057

← back to feed
Revenue (TTM)
$4M
−100.0% YoY Q1 Aug 2024
Net Income (TTM)
−$1.95M
+25.5% YoY Q1 Aug 2024
EPS Diluted (TTM)
−$0.03
−280.0% YoY Q1 Aug 2024
Gross Margin
—
Q1 Aug 2024
Operating Margin
-52.2%
Q1 Aug 2024
Net Margin
-48.8%
Q1 Aug 2024
Free Cash Flow (TTM)
—
Q1 Aug 2024
Cash
$145.58K
Q1 Aug 2024
Total Debt
—
Q1 Aug 2024
Shares Outstanding
172.2M sh
Q1 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings